Exchange Traded Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Buy	3,252 +891	+38%	+$303K	0.01%	784
2025 Q4	$939K	Buy	2,361 +288	+14%	+$127K	0.01%	833
2025 Q3	$945K	Sell	2,073 -733	-26%	-$298K	0.01%	800
2025 Q2	$915K	Sell	2,806 -909	-24%	-$252K	0.01%	714
2025 Q1	$1M	Sell	3,715 -118	-3%	-$30.3K	0.02%	561
2024 Q4	$902K	Buy	3,833 +265	+7%	+$69.7K	0.02%	602
2024 Q3	$981K	Buy	3,568 +136	+4%	+$35.4K	0.02%	519
2024 Q2	$834K	Sell	3,432 -356	-9%	-$56.2K	0.02%	501
2024 Q1	$566K	Sell	3,788 -1,625	-30%	-$271K	0.01%	640
2023 Q4	$1.04M	Buy	5,413 +2,040	+60%	+$347K	0.03%	397
2023 Q3	$597K	Sell	3,373 -4,860	-59%	-$927K	0.02%	520
2023 Q2	$1.56M	Sell	8,233 -13,035	-61%	-$2.58M	0.04%	311
2023 Q1	$4.26M	Buy	21,268 +13,900	+189%	+$2.92M	0.12%	133
2022 Q4	$1.75M	Sell	7,368 -724	-9%	-$154K	0.05%	201
2022 Q3	$1.62M	Sell	8,092 -5,161	-39%	-$984K	0.05%	174
2022 Q2	$1.93M	Sell	13,253 -279	-2%	-$39.6K	0.06%	164
2022 Q1	$2.21M	Buy	13,532 +4,618	+52%	+$704K	0.04%	210
2021 Q4	$1.51M	Sell	8,914 -177	-2%	-$32.9K	0.03%	278
2021 Q3	$1.72M	Sell	9,091 -1,997	-18%	-$375K	0.04%	241
2021 Q2	$1.88M	Buy	11,088 +344	+3%	+$50.4K	0.06%	226
2021 Q1	$1.52M	Buy	10,744 +3,368	+46%	+$507K	0.06%	228
2020 Q4	$959K	Buy	7,376 +4,629	+169%	+$618K	0.04%	234
2020 Q3	$400K	Buy	2,747 +1,272	+86%	+$181K	0.02%	348
2020 Q2	$218K	Buy	1,475 +768	+109%	+$104K	0.04%	458
2020 Q1	$77K	Buy	707 +323	+84%	+$37.3K	0.04%	280
2019 Q4	$44K	Buy	+384	New	+$38.3K	0.01%	283